CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO): Net sales for the first quarter of fiscal 2009, were $34.3 million as compared to $33.8 million for the same period of the prior fiscal year, an increase of $0.5 million or 1%. Net earnings for the first quarter of fiscal 2009 were $8.1 million, or $0.20 per diluted share, up 8% and 11%, respectively, over the first quarter of fiscal 2008. Diluted common shares outstanding for the first quarters of fiscal 2009 and 2008 were 41,125,000 and 40,967,000, respectively.
